Journal Article (Editorial)

DZNE-2026-00349

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Idebenone as a treatment for Leber hereditary optic neuropathy: A plain language summary of the LEROS study publication

Yu-Wai-Man, P. ; Newman, N. J. ; Poincenot, L. ; Ferguson, J. ; Klopstock, T. (Last author)DZNE*

2025
Taylor & Francis Group Abingdon

This record in other databases:  

Please use a persistent id in citations: doi:10.1080/17469899.2025.2563196

---

Contributing Institute(s):

1. Clinical Research (Munich) (Clinical Research (Munich))

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

---

Database coverage:
; Clarivate Analytics Master Journal List ; Emerging Sources Citation Index ; IF < 5 ; JCR ; SCOPUS ; Web of Science Core Collection

---

---

Linked articles:

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Yu-Wai-Man, P. ; Carelli, V. ; Newman, N. J. ; Silva, M. J. ; Linden, A. ; Van Stavern, G. ; Szaflik, J. P. ; Banik, R. ; Lubiński, W. ; Pemp, B. ; Liao, Y. J. ; Subramanian, P. S. ; Misiuk-Hojło, M. ; Newman, S. ; Castillo, L. ; Kocięcki, J. ; Levin, M. H. ; Muñoz-Negrete, F. J. ; Yagan, A. ; Cherninkova, S. ; Katz, D. ; Meunier, A. ; Votruba, M. ; Korwin, M. ; Dziedziak, J. ; Jurkutė, N. ; Harvey, J. P. ; La Morgia, C. ; Priglinger, C. ; Llòria, X. ; Tomasso, L. ; Klopstock, T. (Last author)DZNE* ; Group, L. S. (Collaboration Author)
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Cell reports / Medicine 5(3), 101437 (2024) [10.1016/j.xcrm.2024.101437]2024   Files  Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

---